Medical Cameras Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Medical cameras are used to examine the interior of a hollow organ or cavity of the body for medical purpose and provide investigation of medical symptoms, diagnosis confirmation and also treatment such as widening of a constricted esophagus, extracting off a polyp or removal of a foreign object or cauterization of a bleeding vessel. Surgical procedures using medical cameras are less invasive than traditional surgical procedures.
To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/medical-cameras-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The global medical cameras market is categorized as follows:
- Endoscopy cameras
- Dermatology cameras
- Ophthalmology cameras
- Dental cameras
- Digital imaging (3D/2D)
- Liquid lens technology
- Optical coherence tomography scanner
At present, North America dominates the global medical cameras market and is followed by Europe due to the early entrance of new competitors and corresponding release of new high definition cameras in these regions. Emerging economies of Asia-Pacific, Latin America and Middle East are expected to undergo rapid growth in medical cameras market due to rising demand for minimally invasive surgical procedures and increased adoption of high definition technology.
Some of the major factors driving the global medical cameras market include growing health awareness among the patient base, aging population and related increase in healthcare utilization, better health outcomes and improved efficiency procedures and advancement in HD camera technology.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175726
Some of the prominent players contributing to the global medical cameras market include Carestream Health, Inc., Gendex Corporation, Canon, Inc., Canfield Scientific, Inc., Stryker Corporation, Allied Vision Technologies GmbH, Olympus Corporation, Sensor Technologies America., Inc., and Videology Imaging Solutions, Inc.,
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/175726
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Central Nervous System (CNS) Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/central-nervous-system-cns-biomarkers-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Biomarkers are used to indicate the biological state of a process, pathogenic process or therapeutic action. Biomarkers facilitate understanding the development of a chronic disease, relationship between exposure to environmental chemicals and identification of subgroups of people who are relatively at high risk of developing disease. Continued development in related technologies such as genomics, proteomics and imaging system has accelerated the development of biomarkers. With the complexity of Central Nervous System (CNS), it is considered that biomarkers will play a vital role in identifying several neurodegenerative diseases at early stage, provide more accurate diagnosis and better treatment.
The global market for Central Nervous System biomarkers has been growing rapidly over the past two decades and is expected to continue further under the influence of increased governmental support, rapidly increasing aging population and advancements in supporting technologies such as genomics, proteomics and imaging technologies. The world is witnessing a rapid growth in aging population leading to high prevalence of many CNS disorders such as Parkinson’s, multiple sclerosis and Alzheimer’s disease. The Aging Research Center, Karoliska Institute, Sweden suggests that approximately 24 million are affected with Alzheimer’s disease worldwide.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175728
These diseases incur significant burden on society, to overcome these burdens governments are supporting private and public laboratories by funding to continue their development process. United States government has proposed to spend USD 140.8 billion in the fiscal 2013 to support research and development program across the country. Geographically, North America represents the largest market as healthcare infrastructure ismore advanced as compared to other regions around the globe and it also has a large population base suffering from CNS diseases. The emerging markets including India, china, Brazil and Mexico are poised to show substantial growth due to continuously improving healthcare facilities in these nations.
Hemoglobin A1c Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/hemoglobin-a1c-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Blood glucose testing at regular intervals is very crucial for diabetic patients, in order to keep a track of fluctuating glucose levels in the blood. The crucial aim of diabetes treatment is to ensure normal levels of blood glucose. Hemoglobin A1c (Hb A1c) is a lab test that gives an idea about average levels of blood sugar for a period of around three months. The test results give an idea about the efficacy of diabetes treatment plans. It provides insights on the following parameters:
- Success of the designed diabetes treatment plan.
- Accuracy of test results
The mechanism of test includes linking of hemoglobin to glucose molecules in red blood cells. With increasing levels of glucose in red blood cells, there is a high possibility of hemoglobin molecules being glycated or linked with glucose molecules. It is recommended to perform the test atleast twice in a year. A1c levels are reported in terms of percentages. Presently, American Association of Clinical Endocrinologists recommends around 6.5% A1c to be normal concentration and American Diabetes Association recommends less than 7.0% A1c in the blood cells.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175727
The market for hemoglobin A1c testing is witnessing a consistent growth trend majorly due to increasing incidence of diabetes mellitus across the globe. According to the data enumerated by WHO, there are around 347 million diabetic patients worldwide and diabetes will be seventh leading cause of death by 2030. Currently, with the approval of U.S. FDA for these tests or assays for diagnosing diabetes by healthcare professionals, the demand and acceptance of HbA1c tests will further increase.
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948